Effect of prophylactic ondansetron on postoperative nausea and vomiting in patients on preoperative steroids undergoing craniotomy for supratentorial tumors

Journal of Neurosurgical Anesthesiology

Volumn 19, Issue 4, 2007, Pages 239-242

  Wig, Jyotsna ^a   Chandrashekharappa, Kiran Nagenahalli ^a   Yaddanapudi, Lakshmi Narayana ^a   Nakra, Dhiraj ^a   Mukherjee, Kanchan Kumar ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Ondansetron; PONV; Preoperative steroids; Supratentorial tumors

Indexed keywords

DEXAMETHASONE; GLYCOPYRRONIUM BROMIDE; HALOTHANE; ISOFLURANE; LIDOCAINE; MIDAZOLAM; MORPHINE; NEOSTIGMINE; NITROUS OXIDE; ONDANSETRON; OXYGEN; PLACEBO; STEROID; THIOPENTAL; VECURONIUM;

ADULT; ANESTHESIA INDUCTION; ARTICLE; BRAIN TUMOR; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRANIOTOMY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME; VOMITING;

ADOLESCENT; ADULT; ANESTHESIA, INHALATION; ANTIEMETICS; CRANIOTOMY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTION SICKNESS; ONDANSETRON; POSTOPERATIVE NAUSEA AND VOMITING; PREANESTHETIC MEDICATION; STEROIDS; SUPRATENTORIAL NEOPLASMS;

EID: 34748839551     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/ANA.0b013e3181557471     Document Type: Article

References (24)

1. Fabling JM, Gan TJ, El-Moalem HE, et al. A randomized, double-blinded comparison of ondansetron, droperidol, and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy. Anesth Analg. 2000;91:358-361.
2. Furst SR, Sullivan LJ, Soriano SG, et al. Effects of ondansetron on emesis in the first 24 hours after craniotomy in children. Anesth Analg. 1996;83:325-328.
3. Kathirvel S, Dash HH, Bhatia A, et al. Effect of prophylactic ondansetron on postoperative nausea and vomiting after elective craniotomy. J Neurosurg Anesthesiol. 2001;13:207-212.
4. Madenoglu H, Yildiz K, Dogru K, et al. Randomized, double-blinded comparison of tropisetron and placebo for prevention of postoperative nausea and vomiting after supratentorial craniotomy. J Neurosurg Anesthesiol. 2003;15:82-86.
5. Fabling JM, Gan TJ, Guy J, et al. Postoperative nausea and vomiting: a retrospective analysis in patients undergoing elective craniotomy. J Neurosurg Anesthesiol. 1997;9:308-312.
6. Clarke RSJ. Nausea and vomiting. Br J Anaesth. 1984;56:19-27.
7. Aapro MS, Alberts DS. Dexamethasone as an antiemetic in patients treated with cisplatin. N Engl J Med. 1981;305:520.
8. Fortney JT, Gan TJ, Graczyk S, et al. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. Anesth Analg. 1998;86:731-738.
9. Loewen PS, Marra CA, Zed PJ. 5-HT3 receptor antagonists vs. traditional agents for the prophylaxis of postoperative nausea and vomiting. Can J Anaesth. 2000;47:1008-1018.
10. Pugh SC, Jones NC, Barsoum LZ. A comparison of prophylactic ondansetron and metoclopramide administration in patients undergoing major neurosurgical procedures. Anaesthesia. 1996;51:1162-1164.
11. Sinha PK, Tripathi M, Ambesh SP. Efficacy of ondansetron in prophylaxis of postoperative nausea and vomiting in patients following infratentorial surgery: a placebo-controlled prospective double-blind study. J Neurosurg Anesthesiol. 1999;11:6-10.
12. Fabling JM, Gan TJ, El-Moalem HE, et al. A randomized, double-blind comparison of ondansetron versus placebo for prevention of nausea and vomiting after infratentorial craniotomy. J Neurosurg Anesthesiol. 2002;14:102-107.
13. Smith DB, Newlands ES, Rustin GJS, et al. Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet. 1991;338:487-490.
14. Smith DB, Newlands ES, Spruyt OW, et al. Ondansetron (GR38032F) plus dexamethasone: effective anti-emetic prophylaxis for patients receiving cytotoxic chemotherapy. Br J Cancer. 1990;61:323-324.
15. McKenzie R, Tantisira B, Karambelkar DJ, et al. Comparison of ondansetron with ondansetron plus dexamethasone in the prevention of postoperative nausea and vomiting. Anesth Analg. 1994;79:961-964.
16. Jensen MP, Karoly P, Braver S. The measurement of clinical pain intensity: a comparison of six methods. Pain. 1986;27:117-126.
17. Henzi I, Walder B, Tramer MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg. 2000;90:186-194.
18. Rich W, Abdulhayoglu G, Di Saia PJ. Methylprednisolone as antiemetic during cancer chemotherapy: a pilot study. Gynecol Oncol. 1980;9:193-198.
19. Young SN. Mechanism of decline in rat brain 5-hydroxytryptamine after induction of liver tryptophan pyrrolase by hydrocortisone: roles of tryptophan catabolism and kynurenine synthesis. Br J Pharmacol. 1981;74:695-700.
20. Harris AL. Cytotoxic-therapy induced vomiting is mediated via enkephalin pathways. Lancet. 1982;1:714-716.
21. Wang JJ, Ho S-T, Uen YH, et al. Small-dose dexamethasone reduces nausea and vomiting after laparoscopic cholecystectomy: a comparison of tropisetron with saline. Anesth Analg. 2002;95:229-232.
22. Frederikson M, Hursti T, Furst C, et al. Nausea in cancer chemotherapy is inversely related to urinary cortisol excretion. Br J Cancer. 1992;65:779-780.
23. Sagar S. The current role of anti-emetic drugs in oncology: a recent revolution in patient symptom control. Cancer Treat Rev. 1991;18:95-135.
24. Apfel CC, Kortilla K, Abdalla M, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. NEJM. 2004;350:2441-2451.